Neuroendokrin daganatok: vizsgálatok itt: Kína
62 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Where
- Beijing, Chengdu, Guangzhou, Shanghai
- Életkor
- 12 év and over
- People
- 355 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00 - No phaseTaking peoplePET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique
- Where
- Xi'an
- Életkor
- 18 év to 75 év
- People
- 35
- Run by
- Xijing Hospital
See details and how to joinNCT06914427 - 3. fázisTaking peopleDAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Jinan, Linyi, Luoyang, Nanning, Shanghai, Wuhan, Xiamen, Xi'an, Zhengzhou
- Életkor
- 18 év and over
- People
- 390 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07544654 · EU 2025-523869-22-00 - No phaseCsak meghívásosLiver Transplantation Versus Conventional Medical Therapy for Low-Grade GEP-NET With Liver Metastases
- Where
- Tianjin
- Életkor
- 18 év to 70 év
- People
- 100
- Run by
- Chiyi Chen
See details and how to joinNCT07913113 - 1. fázisTaking peopleA Study of BL-M14D1 in Patients With Locally Advanced or Metastatic Small Cell Lung Cancer, Neuroendocrine Tumors and Other Solid Tumors
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 115
- Run by
- Biokin (Shanghai) Biopharmaceutical Co., Ltd.
See details and how to joinNCT06505824 - No phaseNot yet taking people in KínaImmunotherapy in Neuroendocrine Carcinoma of the Cervix
- Where
- Beijing
- Életkor
- 18 év to 100 év
- People
- 150
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07911423 - 2/3. fázisTaking peopleZanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Where
- Hong Kong
- Életkor
- 18 év and over
- People
- 440 worldwide
- Run by
- Exelixis
See details and how to joinNCT06943755 · EU 2025-521043-20-00 - 1/2. fázisNot yet taking people in KínaDAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Where
- Nanning, Shanghai
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07707895 · EU 2026-525634-27-00 - No phaseTaking peopleIncremental Value of Delayed 68Ga-DOTATATE PET/MR in the Detection of Liver Metastases
- Where
- Fuzhou
- Életkor
- 30 év to 74 év
- People
- 46
- Run by
- First Affiliated Hospital of Fujian Medical University
See details and how to joinNCT07898904 - No phaseCsak meghívásosOxaliplatin-Based Adjuvant Therapy for Gastrointestinal Neuroendocrine Carcinoma**
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 42
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07891572 - 1/2. fázisTaking peopleDose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 265
- Run by
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT06283719 - 3. fázisNot yet taking people in KínaA Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC
- Where
- Anyang, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Jinan, Kunming, Lanzhou, Luoyang, Nanchang, Nanjing, Nanning, Shanghai, Shengyang, Taiyuan, Tianjin, Wenzhou, Xiamen, Xi’an, Xinxiang, Xuzhou, Zhengzhou
- Életkor
- 18 év and over
- People
- 280
- Run by
- Nanjing Leads Biolabs Co.,Ltd
See details and how to joinNCT07720193 - No phaseNot yet taking people in KínaMulti-omics Study of Cervical Neuroendocrine Carcinoma
- Where
- Beijing
- Életkor
- 18 év to 100 év
- People
- 120
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07879339 - No phaseTaking peopleA Comparative Study of Patients Undergoing Surgery for Pituitary Neuroendocrine Tumors Detected by Different Ways
- Where
- Beijing
- Életkor
- 1 év to 85 év
- People
- 5000
- Run by
- Beijing Tiantan Hospital
See details and how to joinNCT07835412 - 2. fázisTaking peopleComparing DLL3 PET/CT to Standard Scans in Neuroendocrine Cancer
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 200
- Run by
- Tingting Yuan
See details and how to joinNCT07733024 - No phaseTaking peopleDLL3-Targeted PET/CT in Neuroendocrine Carcinoma
- Where
- Xiamen
- Életkor
- 18 év to 80 év
- People
- 80
- Run by
- The First Affiliated Hospital of Xiamen University
See details and how to joinNCT07458906 - 2. fázisTaking peopleLenvatinib Plus Chemotherapy for pNET Liver Metastases
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 80
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07835893 - 3. fázisNot yet taking people in KínaZG005 Plus Etoposide and Cisplatin vs. Etoposide and Cisplatin as First-Line Treatment for Advanced Neuroendocrine Carcinoma
- Where
- Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 440
- Run by
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT07833839 - 3. fázisTaking peopleStudy to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
- Where
- Beijing, Shanghai
- Életkor
- 12 év to 100 év
- People
- 240 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06784752 · EU 2024-518325-15-00 - No phaseNot yet taking people in KínaReal-World Study of the Safety and Efficacy of Surufatinib in the Treatment of Neuroendocrine Tumors
- Where
- Xiamen
- Életkor
- 18 év and over
- People
- 60
- Run by
- Yefeng
See details and how to joinNCT07780539 - No phaseTaking peopleUnderwater Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for the Treatment of Small Rectal Neuroendocrine Tumors
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 174
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT07759960 - 1/2. fázisTaking peopleAn Open, Single-center Clinical Study of Surufatinib Combined With Temozolomide and S-1 in the First-line Treatment of Advanced Neuroendocrine Tumors
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 40
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06038461 - 2. fázisTaking peopleDAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Where
- Chengdu, Hangzhou, Jinan, Nanchang, Shanghai
- Életkor
- 18 év and over
- People
- 204 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT05882058 · EU 2023-504247-13-00 - 2/3. fázisTaking peopleA Clinical Study of Lutetium[177Lu] Oxodotreotide Injection in Patients With Advanced Neuroendocrine Neoplasms
- Where
- Shanghai
- Életkor
- 12 év and over
- People
- 85
- Run by
- Sinotau Pharmaceutical Group
See details and how to joinNCT06398444 - 2. fázisNot yet taking people in KínaAK112 Combination Therapy as First Line Treatment for Metastatic Digestive System Neuroendocrine Cancer
- Where
- Baotou, Taiyuan, Tianjin, Tongliao
- Életkor
- 18 év to 75 év
- People
- 56
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07712094